SF
CLMT icon

Synovus Financial’s Calumet Specialty Products CLMT Stock Holding History

Synovus Financial’s Portfolio CLMT Stock Details CLMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-57
Closed -$2K – 942
2013
Q4 		$2K Buy
+57
New +$1.59K ﹤0.01% 861

Other funds holding CLMT

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Edge Asset Management Seattle, Washington $13.2B AUM 19.52% 1-Year Est. Return
AAA
Adams Asset Advisors Dallas, Texas $882M AUM 42% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
IMS
Index Management Solutions Philadelphia, Pennsylvania $101M AUM 12.09% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CA
Corrado Advisors Ramsey, New Jersey $192M AUM 20.53% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Synovus Financial's CLMT Position: Q1 2014 in Review

Synovus Financial sold out of Calumet Specialty Products (CLMT) in Q1 2014, closing a stake of 57 shares — an estimated $2K sold.

Synovus Financial first reported a position in CLMT in Q4 2013 and held it in 1 quarter. The position peaked at $2K in Q4 2013. 115 funds tracked by Wall St. Rank hold CLMT as of Q1 2014.

  • Synovus Financial reported no remaining Calumet Specialty Products position as of Q1 2014 after selling out during the quarter.
  • Synovus Financial sold 57 Calumet Specialty Products shares in Q1 2014, an estimated $2K.
  • Synovus Financial first reported a position in Calumet Specialty Products in Q4 2013 and held it in 1 quarter.
  • Synovus Financial's Calumet Specialty Products position peaked at $2K in Q4 2013.
  • 115 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2014.

Based on Synovus Financial's 13F filing for Q1 2014, filed 7 May 2014.